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Rome ‘‘La Sapienza’’, Rome, Italy; and §UT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, TennesseABSTRACT Prion proteins become pathogenic through misfolding. Here, we characterize the folding of a peptide consisting of
residues 109–122 of the Syrian hamster prion protein (the H1 peptide) and of a more amyloidogenic A117V point mutant that
leads in humans to an inheritable form of the Gerstmann-Stra¨ussler-Scheinker syndrome. Atomistic molecular dynamics simu-
lations are performed for 2.5 ms. Both peptides lose their a-helical starting conformations and assume a b-hairpin that is struc-
turally similar in both systems. In each simulation several unfolding/refolding events occur, leading to convergence of the
thermodynamics of the conformational states to within 1 kJ/mol. The similar stability of the b-hairpin relative to the unfolded state
is observed in the two peptides. However, substantial differences are found between the two unfolded states. A local minimum is
found within the free energy unfolded basin of the A117Vmutant populated by misfolded collapsed conformations of comparable
stability to the b-hairpin state, consistent with increased amyloidogenicity. This population, in which V117 stabilizes a hydro-
phobic core, is absent in the wild-type peptide. These results are supported by simulations of oligomers showing a slightly higher
stability of the associated structures and a lower barrier to association for the mutated peptide. Hence, a single point mutation
carrying only two additional methyl groups is here shown to be responsible for rather dramatic differences of structuring within
the unfolded (misfolded) state.INTRODUCTIONPrion disorders are caused by a structural change of the
cellular form of the prion protein (PrPC) into an abnormal,
infectious scrapie form (PrPSC) (1,2), that accumulates in
the brain as b-sheet-rich amyloid plaques (3). Several
models for the mechanism of the amyloidogenic process
have been proposed and all involve a conformational change
in the protein that leads to the formation of soluble oligo-
mers, the primary cytotoxic species in many cases, which
eventually nucleate the growth of larger fibers (4–9).
Prion diseases can occur sporadically by unknown causes,
by infection or in inherited forms. One of the inherited
forms in humans, the Gerstmann-Stra¨ussler-Scheinker
syndrome, is associated with an alanine-to-valine (A117V)
mutation. This mutation lies within a highly conserved
region (10) corresponding to residues 109–122 of the prion
sequence (the H1 peptide). The conformational change
occurring within the H1 region has been suggested to be
an early step in the conversion of PrPC to PrPSC (11–13),
although the exact mechanism remains unclear. Further-
more, other PrP regions have been suggested to drive the
pathogenic conformational change (14,15).
The experimental characterization of amyloidogenic
proteins and peptides and their structural transitions is often
hampered by their tendency to aggregate. However, useful
information has been obtained by means of computer simu-
lation (5,8,16–22). Homology modeling studies (23) led to
the region corresponding to residues 109–122 in PrPC beingSubmitted November 30, 2010, and accepted for publication April 25, 2011.
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NMR structure of PrPC in solution the structure of this
segment was found to be undefined (24). The isolated H1
peptide adopts a helical conformation in a water/2,2,2-
trifluoroethanol mixture that is rapidly lost in pure water,
in which the peptide forms b-sheet structure from which
amyloid fibrils precipitate (11,25). The inclusion of the
A117V point mutation was found to increase the toxicity
of the peptide (26) and the b-sheet content in the fibrils
(27). However, an explanation at the structural and thermo-
dynamic levels of the higher amyloidogenicity caused by
a single point mutation carrying only two additional methyl
groups (alanine to valine) is still lacking.
In this study, we perform ms timescale atomistic molec-
ular dynamics (MD) simulations in aqueous solution of
the Syrian hamster H1 peptide and the mutated peptide
carrying the A117V point mutation. Both peptides, initially
modeled as a a-helix, spontaneously adopt a b-hairpin
conformation that undergoes several unfolding/refolding
transitions, to a degree permitting a thermodynamic and
kinetic characterization of the folding/unfolding/misfolding
process. Comparison of the two systems reveals significant
differences consistent with the enhanced amyloidogenic
character of the mutated peptide. Simulations of the early
oligomerization process were also performed and show
increased stability of the associated state and a decreased
barrier to association for the mutant, consistent with the
single-peptide results.doi: 10.1016/j.bpj.2011.04.053
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Molecular dynamics simulation protocol
The explicit solvent simulations of the wild-type (WT) H1 peptide
(MKHMAGAAAAGAVV) and of its A117V mutant (MKHMAGAAVA
GAVV) were performed under the same physicochemical conditions with
the same force field for the peptide, namely GROMOS96 (28), and for
the solvent, namely the simple point charge model (29). The simulations
were performed in the NVT ensemble with the isokinetic temperature
coupling to keep the temperature constant at 300 K (30). For the oligomeric
simulations (see below) a higher temperature of 400 K was used to enhance
the configurational sampling. The bond lengths were fixed (31) and a time
step of 2 fs was used for numerical integration of the equations of motion.
The long-range electrostatic interactions were treated with the particle
mesh Ewald method (32), with a real space cutoff of 0.9 nm. Coordinates
were stored every 1 ps. The side chain protonation states reproduce a pH
of ~7. The N- and C-termini were amidated and acetylated, respectively
(11). For the monomeric simulations, one peptide molecule was placed in
a periodic truncated octahedron large enough to containz1.0 nm of water
on all sides, and one negative counter ion (Cl–) was added to neutralize the
system. For the WT peptide 240 ns of MD simulation were performed start-
ing from the a-helix conformation obtained in previous work (33), and
2260 ns starting from the b-hairpin conformation observed during the
previous 240 ns simulation, using a new set of initial velocities, for a total
simulation time of 2.5 ms. For the A117V mutant the same starting struc-
tures as for the WTwere used and with Ala-117 mutated into a Val residue;
850 ns were performed starting from the a-helix and 1650 ns starting from
the b-hairpin conformation, using a new set of initial velocities, for a total
simulation time of 2.5 ms; concerning the choice of the starting configura-
tion, a logical choice is a realistic, but non-beta initial structure, to possibly
observe a transition into some b structure. Hence, rather than from a more
unrealistic extended structure, the simulations were started from a a-helix
conformation obtained in previous work in a 2,2,2-trifluoroethanol /water
mixture (33).
For the oligomer simulations, four monomers with a starting b-hairpin
conformation were placed in a periodic truncated octahedron large enough
to contain z1.0 nm of water on all sides, and four negative counter ions
(Cl–) were added to neutralize the system. The four monomers were
initially arranged in a plane with the turns pointing toward the center of
an ideal circle, to maximize the distance between them while keeping the
box a reasonable size. For both the WT and A117V tetramers the simula-
tions were run for 300 ns.Secondary structure definition
A robust parameter for identifying conformational transitions from the








where Ri,N is the ith interstrand Ca-Ca distance in the b-hairpin (native)
structure and Ri is the same distance in the MD. The five interstrand
Ca-Ca pairs in the H1 peptide hairpin are the following: M109-V121,
K110-A120, H111-A118, M112-A117 (or V117), and A113-A116. A value
of Rz 4.8–5 indicates formation of the b-hairpin. A cut-off value of RR
4.8 was here used to define folded conformations (state f). To analyze the
structural features of nonfolded conformations (R < 4.8), an RMSD (root
mean-square deviation)-based clustering analysis (35) of those configura-
tions with R < 4.8 was performed. Although for the WT peptide the
unfolded structures do not possess persistent structural features, i.e., each
cluster is populated by <5%, for the A117V mutant the highest populated
cluster (z30% of the nonfolded conformations) does exhibit partial struc-turing, involving a b-bridge between H111 and V117 and with the side chain
of V117 being buried, i.e., with a solvent accessible surface area%0.5 nm2.
Hence, for the WT all the nonfolded structures were classified as unfolded
(u state), whereas in the case of the A117Vmutant nonfolded conformations
were themselves clustered into two states, i.e., a completely unfolded
(state u) and misfolded (state m), the latter being the more populated.Essential dynamics analysis
The principles of essential dynamics analysis are described in detail else-
where (36,37). Briefly, the covariance matrix of positional fluctuations
(Ca only) is constructed, from equilibrium MD trajectories and diagonal-
ized. The corresponding eigenvectors are directions in configurational
space and the eigenvalues indicate the mean-square fluctuations along these
axes. The procedure corresponds to a linear multidimensional least squares
fitting of a trajectory in configurational space. Sorting the eigenvectors by
the size of the eigenvalues results in the division of the configurational
space into a low-dimensional (essential) subspace in which most of the
positional fluctuations are confined and a high-dimensional (near-
constraints) subspace in which mostly small vibrations occur. The first
essential eigenvector, ev 1, i.e., that with the largest eigenvalue, accounts
for z45% of the overall positional fluctuations in both the WT and
A117V mutant simulations and is here taken as the folding reaction coordi-
nate (for the justification of this see the Results).Free energy profile evaluation
To obtain the free energy along ev 1, the MD structures sampled every 1 ps
were projected onto 80 bins dividing the overall accessible range. For each
bin (i.e., for each position, q, along ev 1) the number of points was counted
and the relative probability density, req(q), calculated together with the
equilibrium fractions of folded, misfolded, and unfolded conformations.
As the reference state, the bin with the highest probability density req(qref),
i.e., the bin corresponding to the overall free energy minimum, was chosen.
The free energy profile was evaluated as





To check the effect of different grid spacings on the thermodynamic prop-
erties, the free energy profiles were constructed using different numbers of
bins: 40, 50, 60, and 100. All the choices provided similar free energy
profiles, the surface being slightly rougher with the higher (100 bins)
number of bins than with the lower (40 bins).RESULTS AND DISCUSSION
MD simulation of monomers
A structural, thermodynamic, and kinetic analysis of the
folding-unfolding of the H1 peptide at room temperature,
obtained using a long timescale (1 ms) atomistic MD simu-
lation in explicit water, has been previously described
(18,19,33). For this study an additional 2.5 ms simulation
was performed, this time of the A117V mutated H1 peptide,
under the same conditions. Furthermore, the WT H1 peptide
simulation was extended to 2.5 ms.
In both simulations the peptide, initially modeled as
aa-helix, preferentially adopts a b-hairpin conformation that
undergoes several unfolding/refolding transitions. Repre-
sentative structures of the observed b-hairpins and theBiophysical Journal 100(12) 3000–3007
FIGURE 2 Free energy profile, DA(q), as a function of the position q
along the first essential eigenvector for (A) the WT peptide and (B) the
A117V mutant. Equilibrium fraction of folded, f, unfolded, u, and mis-
folded, m, conformations as a function of the position q along the first
essential eigenvector for (C) the WT and (D) the A117V mutant. Error
3002 Daidone et al.time evolution of the R parameter characterizing the
secondary structural state of the peptides (see Methods),
are shown in Fig. 1. The hairpin conformation is very
similar for the two systems. The hairpin of the WT peptide,
for which more detailed experimental data are available, is
consistent with NMR chemical shifts (11) and with a low-
resolution structure derived using x-ray diffraction (25).
Comparing the solvent accessible surface area (SASA) of
the folded hairpin structures (R R 4.8) shows that the
only difference is in residue V117. The slight increase
ofz0.25 nm2 in the SASA of the valine 117 of the mutated
hairpin is due simply to the elongated side chain.
To characterize the folding/unfolding thermodynamics in
the two systems, the free energy profiles of the WT and
A117Vmutated peptides along the first essential eigenvector
(see Methods) were derived and are reported in Figs. 2 A and
B, respectively. The WT peptide is characterized by a down-
hill, almost barrierless, profile. In contrast, the profile of the
A11V mutant is double welled with a free energy barrier
ofz3–5 kJ/mol separating the two wells.FIGURE 1 Representative fully folded b-hairpin structures observed (A)
in the WT and (B) in the A117V simulations. (C) Time evolution of the R
parameter for the WT (top) and A117V mutant (bottom) peptides.
bars shown throughout the manuscript correspond to the standard error of
the mean value of the corresponding property calculated over three subsets
of the trajectory.
Biophysical Journal 100(12) 3000–3007The equilibrium functions of the folded, f, unfolded, u,
and misfolded, m, states (see Methods for the definitions)
are shown as a function of the position q along the first
essential eigenvector (ev 1) for the WT and mutated peptide
in Fig. 2 C and D. For both peptides the folded b-hairpin
structures form the major fraction at the free energy
minimum (at qz0.3 nm), whereas at the minimum the pop-
ulation of the unfolded state u drops toz20%. These results
show that the first essential eigenvector is an appropriate
reaction coordinate for distinguishing between folded and
unfolded conditions.
In the case of the A117V mutant a local minimum is
present in the unfolded basin (at q z1.2 nm), which is
absent in the WT. This local minimum is populated by
a stable misfolded collapsed conformation, m. The corre-
sponding equilibrium distribution as a function of q is
shown in Fig. 2 D.
The structure of the misfolded collapsed conformation,
m, is shown in Fig. 3 A. m is characterized by a b-bridge
between H111 and V117 and b-bends between A118 and
G119 and between A113 and A115. The side chain of
V117 is oriented toward the C-terminal end of the peptide,
forming a stable hydrophobic core. Comparison of the
SASA in the f and m states (Fig. 3 B) shows, indeed,
a smaller solvent-exposed surface area in the misfolded
conformation. Hence, the two extra methyl groups are suffi-
cient to drive the formation of a stable hydrophobic core that
is not stably formed in the WT peptide.
To quantitatively compare the thermodynamics of the two
systems, the stability of the unfolded state relative to that
of the folded (and, when present, misfolded) state was
FIGURE 3 (A) Structure of the misfolded collapsed conformation from
the A117V mutant MD simulations. Left: backbone conformation. Right:
the side chains forming the hydrophobic core. (B) Distribution of the
SASA of the conformations in the f and m states from the A117V mutant
MD simulation.
FIGURE 4 Convergence with time of the free energy change, DAu / f,
corresponding to the transition from the unfolded (u) to the folded (f) state
from the WT (top panel) and A117V (bottom panel) simulations. For the
A117V mutant, the free energy change upon misfolding, DAu/m, is also
shown. The final values at 2.5 ms are the equilibrium free energies and
exhibit statistical accuracy within 1.0 kJ/mol. DAu/f z2.8 5 1 kJ/mol
for the WT and DAu/f z2.8 5 1 kJ/mol, and DAu/m z3.4 5 1 kJ/
mol for the A117V mutant.
Molecular Origin of the GSS Syndrome 3003calculated. Given thermodynamic equilibrium, at constant
temperature and volume, the stability is given by the free
energy difference between u and f(or m)
DAu/f ðor mÞ ¼ RT ln pf ðor mÞ
pu
;
where R is the ideal gas constant, T is the temperature, and
pf(or m) and pu are the probabilities of being in states f(or m)
and u, respectively. Fig. 4 presents the sampling dependence
of the free energy change estimate for the u/ f transition
for the WT and for the u/ f and u/ m transitions for the
A117V peptide. In both simulations convergence of the free
energy values is achieved within z2.5 ms, such that free
energy changes associated with the conformational transi-
tions are obtained to within 1.0 kJ/mol statistical accuracy.
The free energy change for the u/ f transition is similar
in both systems (DAu/ fz2.85 1 kJ/mol) corresponding
to higher stability of the unfolded state relative to the b-
hairpin. The 35 1 kJ/mol values of DAu/ f are consistent
with experimental values ranging from z7 to z3.5 kJ/
mol for various b peptides (38). The u / m free energy
change in A117V is slightly higher than, but within
the statistical noise of, the u / f free energy change
(DAu / m z3.4 5 1 kJ/mol versus DAu / f z2.8 5
1 kJ/mol), and thus the folded and misfolded states are of
comparable stability.Finally, the folding (u / f) and unfolding (f / u)
kinetics were calculated. For the A117V mutant the mis-
folding u/ m and m/ u kinetics were also determined.
The distributions of the mean first passage times for the
different transitions are reported in Fig. 5. The correspond-
ing mean transition times were determined by fitting the
distributions with a biexponential function. This yielded
for all possible transitions two time constants, one, t1, on
the ps timescale (corresponding to relatively uninteresting
fluctuations) and the second, t2, on the ns timescale (see
Table 1). t2 for the folding (u/ f) and unfolding (f/ u)
transitions are similar for the two peptides (t2 z20–25 ns
and t2 z2 ns, respectively), the unfolding transition thus
being one order of magnitude faster than the folding transi-
tion. The u/ m and m/ u transitions, present only in the
A117V mutant, have time constants of t2 z42 ns and
t2 z0.1 ns, respectively. u / m is hence slower than
u / f (z42 ns vs. z23 ns) and m / u is faster than
f/ u (1.8 ns vs. 0.1 ns). Direct transitions between f and
m were never observed in the simulation.MD simulation of oligomers
To study the initial stages of the oligomerization process,
300-ns-long MD simulations of four peptide monomers in
aqueous solution were performed for the WT and the
mutated peptide. For both systems during the simulations
several association events on the nanosecond timescale
occur, as shown by the time dependence of the total solvent
accessible surface area (see Fig. 6 A). The free energy
profiles of theWTand A117Vmutated peptides as a function
of the total SASA is reported in Fig. 6 B and clearly shows,
for both systems, the presence of two well-separatedBiophysical Journal 100(12) 3000–3007
FIGURE 5 Distribution of the mean first passage times for the u/ f and
f / u transitions from the WT peptide (top) and the A117V mutant
(bottom) simulations. For the A117V peptide the u/ m and m/ u distri-
butions are also shown. The biexponential fits are shown with the dashed
line.
FIGURE 6 Time evolution of the total SASA (A) and corresponding free
energy profile, DA, as a function of the total SASA (B) for the oligomeric
simulation of the WT and A117V mutant peptides. Representative b-sheet
oligomeric structures are also given. (C) Distribution of the number of intra-
peptide and interpeptide hydrogen bonds in the simulation of the oligomeric
WT and A117V mutant peptides. (D) Distribution of the SASA fraction of
the side chain of residue A117 (for the WT) and V117 (for the mutant) in
the simulation of the oligomeric WTand A117V mutant peptides. The frac-
tion is given with respect to the corresponding SASA in the starting config-
uration.
3004 Daidone et al.minima, one at z38 nm2 corresponding to aggregated
configurations, and the other atz47–60 nm2, corresponding
to dissociated configurations. Although the two profiles are
very similar, they differ in both the relative stability of
oligomeric structures with respect to dissociated conforma-
tions and the free energy barrier to association. The muta-
tion has the effect of lowering by z1 kJ/mol the free
energy of the oligomers relative to the dissociated structures
and of reducing by z2 kJ/mol the barrier to association,
from z7 kJ/mol to z5 kJ/mol.
A structural analysis revealed that the observed oligomers
contain very heterogeneous b-sheet structures, i.e., they
always involve different parts of different monomers.
Some of the oligomers display b-barrel conformations, in
agreement with previous studies showing transient b-barrel
assemblies in the early aggregation steps of amyloid-form-
ing systems (39). On average, the sheet structures are
characterized by z15 interpeptide hydrogen bonds andTABLE 1 Folding, misfolding, and unfolding time constants
u/f u/m f/u m/u
WT
t1 313 (23) ps – 102 (19) ps –
K1 55% – 55% –
t2 24.0 (5.2) ns – 2.2 (0.3) ns –
K2 45% – 45% –
A117V
t1 176 (32) ps 40 (12) ps 113 (21) ps 20 (8) ps
K1 57% 48% 68% 40%
t2 23.1 (5.8) ns 42.3 (9.1) ns 1.8 (0.2) ns 0.1 (0.03) ns
K2 43% 52% 32% 60%
Transition time distributions (see Fig. 5) were fitted using a biexponential
function: K1e
ðt=t1Þ þ K2eðt=t2Þ. The t1 and t2 are the fast and slow time
constants, respectively, and the K1 and K2 the corresponding amplitudes.
Errors shown throughout the manuscript, here reported in parenthesis,
correspond to the standard error of the mean value of the corresponding
property calculated over three subsets of the trajectory.
Biophysical Journal 100(12) 3000–3007z5 intrapeptide hydrogen bonds (see Fig. 6 C). The mis-
folded conformation sampled by the isolated A117V mutant
was never observed in the oligomeric simulations. Hence,
the oligomerization process involves mainly partly extended
strands, rather than the hairpin conformation used as the
starting structure or the misfolded conformation mentioned
previously. These data suggest that partly extended,
unfolded structures might be precursors of the oligomeriza-
tion process (see scheme in Fig. 7), in accord with the exper-
imental evidence that in the intact PrPC protein residues
109–122 (i.e., the sequence corresponding to the H1
peptide) is structurally disordered (24).
Finally, the solvent accessibility of the side chain of
residue 117 in the WT and mutant oligomeric simulations
was investigated. The SASA of A117 (in the WT) and
V117 (in the mutant) has been divided by the corresponding
SASA in the starting conformation formed by the four
FIGURE 7 Schematic diagram of the folding/misfolding/oligomerization process for the WT (top) and A117Vmutant (bottom) peptides. The side chain of
residue 117 is highlighted. In the monomeric state, the mean first passage times associated with the different transitions are shown. It can be seen that the main
difference is that, although V117 dives the formation of a misfolded monomeric conformation in the mutant simulation, such a misfolded state is not present
in the WT peptide. When more monomers are considered in the same solution, formation of oligomers possessing some b-sheet structure occurs in both
systems on the nanosecond timescale. Again, in contrast to the WT system, in the mutant oligomers the V117 side chains tend to participate in interpeptide
hydrophobic cores. Precursors of the oligomerization process are mainly partly extended, unfolded peptide units in both systems. The formation of oligomers
will eventually nucleate the growth of large fibrils on much longer timescales (at least hours). Nucleation of mature fibers was not studied in this work.
Molecular Origin of the GSS Syndrome 3005hairpin monomers to provide information on the fraction of
surface that becomes buried upon clustering (see Fig. 6 D).
It can be seen that while for the WT system the A117 side
chain remains rather exposed to the solvent (the distribution
of the SASA fraction being peaked atz1), the SASA of the
V117 side chain of the mutant reduces toz60% of the cor-
responding SASA in the initial configuration. Hence, upon
clustering of the mutant, the side chains of V117 become
involved in hydrophobic cores, in contrast to the A117
side chains of the WT that remain mainly solvent exposed
(see scheme in Fig. 7).
It has been suggested that in the stable, mature fibers of
both the WT and mutated H1 peptide, the monomers are
aligned in an antiparallel fashion with only residues
112–122 (the hydrophobic core) participating to the b-sheets
(40,41) (see scheme in Fig. 7). However, the observation of
the nucleation of a stable core acting as precursor of the
fibrillization process is beyond the scope of this work and
would require much longer trajectories or coarse-grained
simulations (20–22,42–44).CONCLUSIONS
There is a considerable interest in understanding the molec-
ular mechanisms of misfolding in prion and other amyloid
diseases, such as Alzheimer’s, Huntington’s, and Parkinson’s
(1,45–47) and there is hope that this understanding might
eventually lead to new therapies for these illnesses. Prion
diseases can occur in inherited forms characterized by an early
onset of the disease and aggravated severity. The majority of
the familial forms originate from single-point mutations.In this work, the effect of the Gerstmann-Stra¨ussler-
Scheinker alanine-to-valine mutation on the structure, ther-
modynamics, and kinetics of the H1 prion peptide in
aqueous solution is studied by means of long (2.5 ms) MD
simulations in explicit water. Both the WT and A117V
peptides, initially modeled as a a-helix, spontaneously
form a similar b-hairpin conformation, in which the side
chain of residue 117 is exposed to the solvent, the only slight
difference being an increase of z0.25 nm2 of the exposed
surface area of residue 117 in the A117V peptide. In
contrast to the folded state, dramatic effects are seen in
the unfolded states of the two peptides. A stable misfolded
conformation populates a local minimum in the unfolded
basin of the mutated A117V peptide, in which the residue
V117 is buried in a hydrophobic core. No stable misfolded
hydrophobic core is present in the WT.
The higher tendency observed for the isolated A117V
peptide to form misfolded, compact conformations is
consistent with the higher aggregation propensity experi-
mentally observed for the mutated peptide. Simulation of
the initial oligomerization process of four peptide mono-
mers for the WT and mutated peptides qualitatively
confirms this hypothesis, showing (within the 300 ns simu-
lation time) slightly higher stability of the oligomeric struc-
tures and a lower barrier to association for the mutated
peptide relative to the WT system. No experimental data
exist on the early oligomerization stages in the two systems.
However, a similar effect, supporting our results, was
observed in the case of an Alzheimer’s amyloid b-peptide
for which the E22Q mutation was found to lower the barrier
for monomer deposition onto a pre-formed fibril (8).Biophysical Journal 100(12) 3000–3007
3006 Daidone et al.In the intact PrPC protein the A117V mutation lies within
a highly conserved region that is structurally disordered
(24). This suggests that the conformational change within
this region, that is thought to be an early step in the conver-
sion of PrPC to PrPSC (11,12), takes place from an unfolded
conformation rather than from a folded structure. In accord
with these data on the intact PrPC, partly extended configu-
rations are found here as the dominant components of the
oligomers. Hence, the structural and thermodynamic differ-
ences observed in the unfolded state of the WT and mutant
systems might explain the higher misfolding propensity
induced by the mutation.
Concerning the kinetics, the folding transition (from
unfolded to b-hairpin conformations) is shown to be on
the order of tens of nanoseconds in both systems. However,
in the A117V mutant an additional transition occurs on the
ns timescale, corresponding to the misfolding transition
from the unfolded to the collapsed, misfolded state (see
scheme in Fig. 7). Folding times of the order of tens of nano-
seconds are faster than the known folding times for non-
amyloidogenic b-peptides (the fastest being z260 ns
(38,48,49)) and of the same order of magnitude as for
a-helices. Although this may be due in part to limitations
arising from the empirical force fields used, it is likely to
also reflect the amyloidogenic nature of the peptides studied
(11) and is consistent with the very high alanine content
reducing the entropic costs for the b-hairpin formation
(48) (similarly to alanine-rich helices).
Finally, and more generally, the present results highlight
the need, when characterizing the effects of mutations on
peptide and protein stability, to consider structural changes
occurring in the unfolded state (50–54). Focusing solely on
changes occurring in the native state can miss effects crucial
to the folding/misfolding process.
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